ALNY
Alnylam Pharmaceuticals, Inc.Healthcare$318.85
▲ Bullish
Mkt Cap: $42.29B|Float: 132.1M|SI: 3.3%|DTC: 4.2
Data as of market close Apr 2, 2026
IV Rank
74
IV Pctl
22%
HV 20d
36.0%
52W Range
$206-$496
ATR(14)
$11.48
Exp. Move
±6.7%
P/C Ratio
0.37
Earnings
Apr 30
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
ALNY Key Options Data
- IV Rank
- 73.6%
- Total GEX
- $0.00B
- Total DEX
- $0.9M
- Max Pain
- $270.00
- Expected Move
- ±6.7%
- Put/Call OI
- 0.37
- Net Premium
- $0.5M
- Spot Price
- $318.85
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$21.45 | ±6.7% | $297.40 | $340.30 |
| 2026-05-15 | 43 | ±$41.60 | ±13.1% | $277.25 | $360.45 |
| 2026-06-18 | 77 | ±$54.40 | ±17.1% | $264.45 | $373.25 |
| 2026-07-17 | 106 | ±$62.70 | ±19.7% | $256.15 | $381.55 |
| 2026-09-18 | 169 | ±$81.55 | ±25.6% | $237.30 | $400.40 |
| 2027-01-15 | 288 | ±$102.95 | ±32.3% | $215.90 | $421.80 |
Explore ALNY options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.